154 related articles for article (PubMed ID: 31564412)
1. Prevention of post-ischemic seizure by rapamycin is associated with deactivation of mTOR and ERK1/2 pathways in hyperglycemic rats.
Yang X; Hei C; Liu P; Li PA
Biochem Biophys Res Commun; 2019 Nov; 520(1):47-53. PubMed ID: 31564412
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR signaling Confers Protection against Cerebral Ischemic Injury in Acute Hyperglycemic Rats.
Hei C; Liu P; Yang X; Niu J; Li PA
Int J Biol Sci; 2017; 13(7):878-887. PubMed ID: 28808420
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling.
Liu P; Yang X; Hei C; Meli Y; Niu J; Sun T; Li PA
Int J Biol Sci; 2016; 12(8):1032-40. PubMed ID: 27489506
[TBL] [Abstract][Full Text] [Related]
4. The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice.
Hartman AL; Santos P; Dolce A; Hardwick JM
PLoS One; 2012; 7(9):e45156. PubMed ID: 22984623
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin has paradoxical effects on S6 phosphorylation in rats with and without seizures.
Chen L; Hu L; Dong JY; Ye Q; Hua N; Wong M; Zeng LH
Epilepsia; 2012 Nov; 53(11):2026-33. PubMed ID: 23145776
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 is associated with seizures following ischemia with hyperglycemia.
Liang Y; Lei Z; Zhang H; Xu Z; Cui Q; Xu ZC
Brain Res; 2014 Nov; 1590():75-84. PubMed ID: 25223904
[TBL] [Abstract][Full Text] [Related]
7. mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia.
Yang GS; Zhou XY; An XF; Liu XJ; Zhang YJ; Yu D
Mol Med Rep; 2018 Apr; 17(4):5821-5829. PubMed ID: 29484389
[TBL] [Abstract][Full Text] [Related]
8. A 2-Min Transient Ischemia Confers Cerebral Ischemic Tolerance in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and Neuroinflammation.
Park JH; Ahn JH; Song M; Kim H; Park CW; Park YE; Lee TK; Lee JC; Kim DW; Lee CH; Hwang IK; Yan BC; Ryoo S; Kim YM; Kang IJ; Won MH; Choi SY
Cells; 2019 Sep; 8(10):. PubMed ID: 31546722
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats.
Huang X; McMahon J; Yang J; Shin D; Huang Y
Neuroscience; 2012 Sep; 219():33-47. PubMed ID: 22613737
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
Chi X; Huang C; Li R; Wang W; Wu M; Li J; Zhou D
J Mol Neurosci; 2017 Apr; 61(4):553-562. PubMed ID: 28229367
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment.
Macias M; Blazejczyk M; Kazmierska P; Caban B; Skalecka A; Tarkowski B; Rodo A; Konopacki J; Jaworski J
PLoS One; 2013; 8(5):e64455. PubMed ID: 23724051
[TBL] [Abstract][Full Text] [Related]
14. The mechanistic target of rapamycin (mTOR) pathway and S6 Kinase mediate diazoxide preconditioning in primary rat cortical neurons.
Dutta S; Rutkai I; Katakam PV; Busija DW
J Neurochem; 2015 Sep; 134(5):845-56. PubMed ID: 26016889
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium.
Xu C; Zhang H; Liu C; Zhu Y; Wang X; Gao W; Huang S; Chen L
Oncotarget; 2015 Aug; 6(25):21452-67. PubMed ID: 26046303
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mTOR Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia.
Yang X; Hei C; Liu P; Song Y; Thomas T; Tshimanga S; Wang F; Niu J; Sun T; Li PA
Int J Biol Sci; 2015; 11(12):1424-35. PubMed ID: 26681922
[TBL] [Abstract][Full Text] [Related]
17. Remote ischemic postconditioning protects the brain from focal ischemia/reperfusion injury by inhibiting autophagy through the mTOR/p70S6K pathway.
Chen GZ; Shan XY; Li XS; Tao HM
Neurol Res; 2018 Mar; 40(3):182-188. PubMed ID: 29369005
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of low dose of rapamycin in preventing seizure-induced anxiety-like behaviour, cognitive impairment, and defects in neurogenesis in developing rats.
Liu F; Wu M; Kai J; Dong J; Zhang B; Liu L; Zhu F; Zeng LH
Int J Neurosci; 2020 Jan; 130(1):9-18. PubMed ID: 29883228
[No Abstract] [Full Text] [Related]
19. Pyrazolo[4,3-c]pyridine-4-one (PP-4-one) Exhibits Anti-Epileptogenic Effect in Rat Model of Traumatic Epilepsy by Mammalian Target of Rapamycin (mTOR) Signaling Pathway Downregulation.
Jin J; Shen X; Tian L; He G; Zhang Y
Med Sci Monit; 2020 Jul; 26():e923919. PubMed ID: 32687486
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
